Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia
about
Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistanceCombining functional and structural genomics to sample the essential Burkholderia structomeRespiratory Microbiome of Endangered Southern Resident Killer Whales and Microbiota of Surrounding Sea Surface Microlayer in the Eastern North PacificMolecular Simulations of Carbohydrates with a Fucose-Binding Burkholderia ambifaria Lectin Suggest Modulation by Surface Residues Outside the Fucose-Binding Pocket.Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivoransFosmidomycin decreases membrane hopanoids and potentiates the effects of colistin on Burkholderia multivorans clinical isolatesInhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptideHigh confidence prediction of essential genes in Burkholderia cenocepacia.Efflux pump-mediated drug resistance in Burkholderia.Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria.Anti-Biofilm and Immunomodulatory Activities of Peptides That Inhibit Biofilms Formed by Pathogens Isolated from Cystic Fibrosis Patients.Functional Genome Screening to Elucidate the Colistin Resistance Mechanism.Insect Gut Symbiont Susceptibility to Host Antimicrobial Peptides Caused by Alteration of the Bacterial Cell Envelope.Candidate Essential Genes in Burkholderia cenocepacia J2315 Identified by Genome-Wide TraDISBacterial Evasion of Host Antimicrobial Peptide DefensesBacterial strategies of resistance to antimicrobial peptides.Resistance to antimicrobial peptides in Gram-negative bacteria.Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections.Polymyxin: Alternative Mechanisms of Action and Resistance.Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.Antibiotic resistance in Burkholderia speciesBurkholderia cenocepacia Lipopolysaccharide Modification and Flagellin Glycosylation Affect Virulence but Not Innate Immune Recognition in Plants.Partner associations across sympatric broad-headed bug species and their environmentally acquired bacterial symbionts.The Essential Genome of Burkholderia cenocepacia H111.Genome analysis of NDM-1 producing Morganella morganii clinical isolate.Targeting the nonmevalonate pathway in Burkholderia cenocepacia increases susceptibility to certain β-lactam antibiotics.Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam.Absence of in vitro innate immunomodulation by insect-derived short proline-rich antimicrobial peptides points to direct antibacterial action in vivo.Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance inBurkholderia cenocepacia†
P2860
Q26991811-54B7C522-F3DE-4B5E-BD31-A78534694D08Q27676144-3D77A3E8-742E-4809-9EAE-D9071B374A0DQ30356460-2ED5A288-65C2-4AEB-92DD-936500108C09Q33819308-C69DE916-E224-4EBB-A8AB-57AC9F3DB5D3Q34049989-40063771-9629-4C7E-B795-D616AE665F7BQ34057514-750F3AE4-7897-4E77-A448-B2ED23D0F46DQ34165875-85FF2869-2756-41E7-A230-86AD92BC496EQ34328631-B773BFAB-336F-45B4-8B0C-421C8B09FE4BQ35407877-955C9A7F-3555-4845-8532-790EBBA5627DQ35541353-16239C00-0E37-465D-834D-25167F9FFFE5Q35890186-B56CB577-331A-49BE-B437-2054D8F1C3AAQ35961832-3CBF908F-E203-495A-9034-305BCB9DB416Q35978283-92ACE2C2-716A-4830-B7DB-FAAA2C3AE3FCQ36123634-F836516D-580A-429A-91CF-70E055E4E060Q36720179-39524A66-2BE8-4486-ACC5-FCDA3089D7B9Q36920921-8C86D39B-9154-4CB7-B022-8DB2336D5920Q37984651-F3133D34-5C3A-4CBB-838D-FBFAD5277432Q38263995-7AB3FED0-ABF7-40A1-91EF-A9AAF8BF594BQ38922536-1F04CA12-BC97-4E4B-A2E2-F4ECB7BEBA3DQ40054770-729EEC02-859A-4E62-AC3F-BFDEDB0735B8Q40542863-B97281F2-2FC7-466F-A59E-37E192B9FD3EQ41183502-48F21AFC-58A7-4B53-966E-9BA069E807D2Q45393211-6C48F6AD-23B3-46F8-89F8-4C4A9E94240AQ46315445-4BCCEBF1-C0FC-459A-83C4-361985AE6E63Q46857966-BC0732FE-1983-4FB4-9EE7-13E39449C0E7Q49025273-C7B7280C-A82E-46BC-95D1-7461B29C8EB5Q52339989-DC5237EF-0BEE-4B92-8BEE-04EDA32B8CE6Q52742866-B1999116-2477-485D-8AEA-2AB2CB6E8985Q57837837-4D651A24-8525-479F-AE9E-665084A22ED9
P2860
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia
@en
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia.
@nl
type
label
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia
@en
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia.
@nl
prefLabel
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia
@en
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia.
@nl
P2860
P356
P1476
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia
@en
P2093
Miguel A Valvano
Slade A Loutet
P2860
P356
10.3389/FMICB.2011.00159
P577
2011-07-22T00:00:00Z